In this episode, Dr. Soeren Mattke, physician and health services researcher at the University of Southern California, explores the growing role of blood-based biomarkers in the diagnosis and evaluation of Alzheimer’s disease.

He discusses how blood tests could make Alzheimer’s diagnosis faster, more accurate, and more scalable, helping to reduce pressure on specialist services and integrate diagnosis more effectively into primary care. The episode also examines their potential applications beyond initial detection, including disease staging, risk stratification, prognostication, and treatment monitoring.